NV
Novartis Venture Fund
Novartis Venture Fund is a Series A to Series C stage investment firm. It has made 39 investments. Average disclosed round size is $52.2M (across 34 rounds with reported amounts).
Portfolio
39
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
MS
Michal Silverberg
Managing Director
AC
Adam Cotton
Principal
MM
Michelle Ma
Associate
AK
Anja König
Global Head
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
47 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAlesta | Series A | — | Jan 2025 |
 HYKU Biosciences | Seed | $64M | Nov 2024 |
 LoQus23 | Series A | $43M | Oct 2024 |
| EEpsilogen Ltd | Series B | — | Sep 2024 |
 Averna Tx | Series A | $82M | Jan 2024 |
| AAverna | Series A | $82M | Jan 2024 |
| LoQus23 | Series A | — | Jan 2024 |
 Aravax | Series B | $42.2M | Jan 2022 |
| DDECIPHEX LIMITED | Series B | — | Jan 2022 |
| RRibon | Series B | $65M | Jul 2021 |
| AAmphista | Series B | $53M | Mar 2021 |
| LoQus23 | Seed | — | Jan 2021 |
| IImmPACT Bio | Series A | — | Aug 2020 |
 Ayala Pharmaceuticals | Series B | $30M | May 2020 |
 Escape Bio | Series A | $73M | Jan 2020 |
| SSomaLogic, Inc. | Series A | $81M | Jan 2020 |
 Renovacor | Series A | $11M | Jan 2019 |
| RRibon | Series B | $75M | Jan 2019 |
| RRenovacor | Series A | $11M | Jan 2019 |
| RRenovacor | Series A | $11M | Jan 2019 |
 Galera | Series C | — | Sep 2018 |
| AAkouos | Series A | $50M | Aug 2018 |
 ROX Medical | Series E | $40M | Sep 2016 |
| MMerganser Biotech | Series A | $28M | Feb 2015 |
| Escape Bio | Unknown | $55M | Jan 2015 |
Page 1 of 2
Top Co-Investors
Novartis Pharma AG8 shared
OrbiMed5 shared
New Leaf Venture Partners5 shared
Andera Partners4 shared
Domain Associates4 shared
Pfizer Ventures4 shared
Forbion4 shared
Sunstone Life Science Ventures4 shared
Sofinnova Partners3 shared
RA Capital Management3 shared
Takeda Ventures, Inc.3 shared
Osage University Partners3 shared
Versant Ventures3 shared
Broadview Ventures3 shared
Innogest Capital3 shared
The Invus Group, LLC3 shared
AbbVie3 shared
Foresite Capital3 shared
Omega Funds3 shared
Novo Holdings3 shared
Last updated: 8 September 2026